213 related articles for article (PubMed ID: 22522453)
1. The Proto-oncogene PKCι regulates the alternative splicing of Bcl-x pre-mRNA.
Shultz JC; Vu N; Shultz MD; Mba MU; Shapiro BA; Chalfant CE
Mol Cancer Res; 2012 May; 10(5):660-9. PubMed ID: 22522453
[TBL] [Abstract][Full Text] [Related]
2. SAP155 Binds to ceramide-responsive RNA cis-element 1 and regulates the alternative 5' splice site selection of Bcl-x pre-mRNA.
Massiello A; Roesser JR; Chalfant CE
FASEB J; 2006 Aug; 20(10):1680-2. PubMed ID: 16790528
[TBL] [Abstract][Full Text] [Related]
3. Melanoma Differentiation-associated Gene 7/IL-24 Exerts Cytotoxic Effects by Altering the Alternative Splicing of Bcl-x Pre-mRNA via the SRC/PKCδ Signaling Axis.
Shapiro BA; Vu NT; Shultz MD; Shultz JC; Mietla JA; Gouda MM; Yacoub A; Dent P; Fisher PB; Park MA; Chalfant CE
J Biol Chem; 2016 Oct; 291(41):21669-21681. PubMed ID: 27519412
[TBL] [Abstract][Full Text] [Related]
4. Identification of two RNA cis-elements that function to regulate the 5' splice site selection of Bcl-x pre-mRNA in response to ceramide.
Massiello A; Salas A; Pinkerman RL; Roddy P; Roesser JR; Chalfant CE
J Biol Chem; 2004 Apr; 279(16):15799-804. PubMed ID: 14734550
[TBL] [Abstract][Full Text] [Related]
5. Group VIA Phospholipase A2 (iPLA2β) Modulates Bcl-x 5'-Splice Site Selection and Suppresses Anti-apoptotic Bcl-x(L) in β-Cells.
Barbour SE; Nguyen PT; Park M; Emani B; Lei X; Kambalapalli M; Shultz JC; Wijesinghe D; Chalfant CE; Ramanadham S
J Biol Chem; 2015 Apr; 290(17):11021-31. PubMed ID: 25762722
[TBL] [Abstract][Full Text] [Related]
6. De novo ceramide regulates the alternative splicing of caspase 9 and Bcl-x in A549 lung adenocarcinoma cells. Dependence on protein phosphatase-1.
Chalfant CE; Rathman K; Pinkerman RL; Wood RE; Obeid LM; Ogretmen B; Hannun YA
J Biol Chem; 2002 Apr; 277(15):12587-95. PubMed ID: 11801602
[TBL] [Abstract][Full Text] [Related]
7. Protein kinase C-dependent control of Bcl-x alternative splicing.
Revil T; Toutant J; Shkreta L; Garneau D; Cloutier P; Chabot B
Mol Cell Biol; 2007 Dec; 27(24):8431-41. PubMed ID: 17923691
[TBL] [Abstract][Full Text] [Related]
8. PKC-ι promotes glioblastoma cell survival by phosphorylating and inhibiting BAD through a phosphatidylinositol 3-kinase pathway.
Desai S; Pillai P; Win-Piazza H; Acevedo-Duncan M
Biochim Biophys Acta; 2011 Jun; 1813(6):1190-7. PubMed ID: 21419810
[TBL] [Abstract][Full Text] [Related]
9. Suppression of 5' splice-sites through multiple exonic motifs by hnRNP L.
Loh TJ; Choi N; Moon H; Jang HN; Liu Y; Zhou J; Zheng X; Shen H
Biochim Biophys Acta Gene Regul Mech; 2017 Mar; 1860(3):363-373. PubMed ID: 28119102
[TBL] [Abstract][Full Text] [Related]
10. Synergy between phosphatidylinositol 3-kinase/Akt pathway and Bcl-xL in the control of apoptosis in adenocarcinoma cells of the lung.
Qian J; Zou Y; Rahman JS; Lu B; Massion PP
Mol Cancer Ther; 2009 Jan; 8(1):101-9. PubMed ID: 19139118
[TBL] [Abstract][Full Text] [Related]
11. Chemical perturbation of Mcl-1 pre-mRNA splicing to induce apoptosis in cancer cells.
Gao Y; Koide K
ACS Chem Biol; 2013 May; 8(5):895-900. PubMed ID: 23485022
[TBL] [Abstract][Full Text] [Related]
12. Regulation of HPV16 E6 and MCL1 by SF3B1 inhibitor in head and neck cancer cells.
Gao Y; Trivedi S; Ferris RL; Koide K
Sci Rep; 2014 Aug; 4():6098. PubMed ID: 25139387
[TBL] [Abstract][Full Text] [Related]
13. Divergence in the anti-apoptotic signalling pathways used by nerve growth factor and basic fibroblast growth factor (bFGF) in PC12 cells: rescue by bFGF involves protein kinase C delta.
Wert MM; Palfrey HC
Biochem J; 2000 Nov; 352 Pt 1(Pt 1):175-82. PubMed ID: 11062070
[TBL] [Abstract][Full Text] [Related]
14. Sulfatase 2 protects hepatocellular carcinoma cells against apoptosis induced by the PI3K inhibitor LY294002 and ERK and JNK kinase inhibitors.
Lai JP; Sandhu DS; Yu C; Moser CD; Hu C; Shire AM; Aderca I; Murphy LM; Adjei AA; Sanderson S; Roberts LR
Liver Int; 2010 Nov; 30(10):1522-8. PubMed ID: 21040406
[TBL] [Abstract][Full Text] [Related]
15. Alternative splicing of caspase 9 is modulated by the phosphoinositide 3-kinase/Akt pathway via phosphorylation of SRp30a.
Shultz JC; Goehe RW; Wijesinghe DS; Murudkar C; Hawkins AJ; Shay JW; Minna JD; Chalfant CE
Cancer Res; 2010 Nov; 70(22):9185-96. PubMed ID: 21045158
[TBL] [Abstract][Full Text] [Related]
16. Specific G-quadruplex ligands modulate the alternative splicing of Bcl-X.
Weldon C; Dacanay JG; Gokhale V; Boddupally PVL; Behm-Ansmant I; Burley GA; Branlant C; Hurley LH; Dominguez C; Eperon IC
Nucleic Acids Res; 2018 Jan; 46(2):886-896. PubMed ID: 29156002
[TBL] [Abstract][Full Text] [Related]
17. Antagonistic effects of the SRp30c protein and cryptic 5' splice sites on the alternative splicing of the apoptotic regulator Bcl-x.
Cloutier P; Toutant J; Shkreta L; Goekjian S; Revil T; Chabot B
J Biol Chem; 2008 Aug; 283(31):21315-24. PubMed ID: 18534987
[TBL] [Abstract][Full Text] [Related]
18. Relative strength of 5' splice-site strength defines functions of SRSF2 and SRSF6 in alternative splicing of Bcl-x pre-mRNA.
Choi N; Liu Y; Oh J; Ha J; Ghigna C; Zheng X; Shen H
BMB Rep; 2021 Mar; 54(3):176-181. PubMed ID: 33050987
[TBL] [Abstract][Full Text] [Related]
19. Bcl-x(S) induces an NGF-inhibitable cytochrome c release.
Lindenboim L; Schlipf S; Kaufmann T; Borner C; Stein R
Exp Cell Res; 2004 Jul; 297(2):392-403. PubMed ID: 15212942
[TBL] [Abstract][Full Text] [Related]
20. A small molecule inhibitor of atypical protein kinase C signaling inhibits pancreatic cancer cell transformed growth and invasion.
Butler AM; Scotti Buzhardt ML; Erdogan E; Li S; Inman KS; Fields AP; Murray NR
Oncotarget; 2015 Jun; 6(17):15297-310. PubMed ID: 25915428
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
